GCMUX
Price
$42.64
Change
+$0.18 (+0.42%)
Updated
Aug 14 closing price
Net Assets
1.21B
VMCIX
Price
$92.45
Change
+$0.26 (+0.28%)
Updated
Aug 14 closing price
Net Assets
224.68B
Interact to see
Advertisement

GCMUX vs VMCIX

GCMUX vs VMCIX Comparison Chart in %
View a ticker or compare two or three
VS
GCMUX vs. VMCIX commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCMUX is a Buy and VMCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCIX has more cash in the bank: 225B vs. GCMUX (1.21B). VMCIX pays higher dividends than GCMUX: VMCIX (1.32) vs GCMUX (0.92). GCMUX was incepted earlier than VMCIX: GCMUX (11 years) vs VMCIX (28 years). GCMUX (0.83) is less costly to investors than VMCIX (0.03). GCMUX is a more actively managed with annual turnover of: 73.00 vs. VMCIX (16.00). GCMUX (5000000) and VMCIX (5000000) have matching initial minimum investment requirements. VMCIX annual gain was more profitable for investors over the last year : 17.84 vs. GCMUX (11.32). VMCIX return over 5 years is better than : 39.33 vs. GCMUX (-0.82).
GCMUXVMCIXGCMUX / VMCIX
Total Expense Ratio0.830.032,767%
Annual Report Gross Expense Ratio0.830.032,767%
Fund Existence11 years28 years-
Gain YTD21.38416.226132%
Front LoadN/AN/A-
Min. Initial Investment50000005000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.21B225B1%
Annual Yield % from dividends0.921.3270%
Returns for 1 year11.3217.8463%
Returns for 3 years28.4955.5451%
Returns for 5 years-0.8239.33-2%
Returns for 10 years30.76166.2519%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRRX42.34N/A
N/A
MFS International Growth R1
SSPIX115.71N/A
N/A
SEI S&P 500 Index F (SIMT)
TPYCX9.06N/A
N/A
Touchstone Sands Capital Intl Gr Eq C
FASEX63.90N/A
N/A
Nuveen Mid Cap Value Opportunities A
BMSTX18.24N/A
N/A
MFS Blended Research Mid Cap Eq R3